+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention



Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention



Biochimica et Biophysica Acta. Molecular Basis of Disease 1863(8): 2070-2077



Diabetic cardiomyopathy is a chronic and irreversible heart complication in diabetic patients, and is characterized by complex pathophysiologic events including early diastolic dysfunction, cardiac hypertrophy, ventricular dilation and systolic dysfunction, eventually resulting in heart failure. Despite these characteristics, the underlying mechanisms leading to diabetic cardiomyopathy are still elusive. Recent studies have implicated microRNA, a small and highly conserved non-coding RNA molecule, in the etiology of diabetes and its complications, suggesting a potentially novel approach for the diagnosis and treatment of diabetic cardiomyopathy. This brief review aims at capturing recent studies related to the role of microRNA in diabetic cardiomyopathy. This article is part of a Special Issue entitled: Genetic and epigenetic control of heart failure - edited by Jun Ren & Megan Yingmei Zhang.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 060216722

Download citation: RISBibTeXText

PMID: 28344129

DOI: 10.1016/j.bbadis.2017.03.013


Related references

Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides. Cardiovascular Diabetology 17(1): 43, 2018

Role of tissue transglutaminase in the pathogenesis of diabetic cardiomyopathy and the intervention effect of rutin. Experimental and Therapeutic Medicine 9(4): 1103-1108, 2015

Basic science of diabetic cardiomyopathy a mechanism and role of mitochondria dysfunction. Diabetes Research and Clinical Practice 120: S11-S12, 2016

MicroRNA-193-5p modulates angiogenesis through IGF2 in type 2 diabetic cardiomyopathy. Biochemical and Biophysical Research Communications 491(4): 876-882, 2017

Modulation of AT-1R/AMPK-MAPK cascade plays crucial role for the pathogenesis of diabetic cardiomyopathy in transgenic type 2 diabetic (Spontaneous Diabetic Torii) rats. Biochemical Pharmacology 83(5): 653-660, 2012

Mitochondrial Calpain-1 Disrupts ATP Synthase and Induces Superoxide Generation in Type 1 Diabetic Hearts: A Novel Mechanism Contributing to Diabetic Cardiomyopathy. Diabetes 65(1): 255-268, 2016

Study on the expression and mechanism of plasma microRNA-21 in patients with ischemic cardiomyopathy. European Review for Medical and Pharmacological Sciences 21(20): 4649-4653, 2017

MicroRNA-146a expression and its intervention in NF-кB signaling pathway in diabetic rat aorta. Endocrine Regulations 48(2): 103-108, 2014

Potential role of cyanidin 3-glucoside (C3G) in diabetic cardiomyopathy in diabetic rats: An in vivo approach. Saudi Journal of Biological Sciences 25(3): 500-506, 2018

Benefits of coronary revascularisation in diabetic and non-diabetic patients with ischaemic cardiomyopathy: role of myocardial viability. European Journal of Heart Failure 8(3): 314-320, 2006

Altered acetylcholine and norepinephrine concentrations in diabetic rat hearts. Role of parasympathetic nervous system in diabetic cardiomyopathy. Diabetes 38(2): 231-236, 1989

MicroRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cellular Immunology 260(2): 70-74, 2010

Tempol ameliorates cardiac fibrosis in streptozotocin-induced diabetic rats: role of oxidative stress in diabetic cardiomyopathy. Naunyn-Schmiedeberg's Archives of Pharmacology 386(12): 1071-1080, 2013

Gene expression profiling in hearts of diabetic mice uncovers a potential role of estrogen-related receptor γ in diabetic cardiomyopathy. Molecular and Cellular Endocrinology 430: 77-88, 2016

Effect of mitochondrial dysfunction in diabetic cardiomyopathy and intervention of traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi 43(1): 8, 2018